Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 16, 2020Molecular MedicineOpen Access

Erythropoietin as candidate for supportive treatment of severe COVID-19

View Full Paper
Ask AI
Bookmark
Share

Authors

HEHannelore EhrenreichKWKarin WeißenbornMBMartin Begemann

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ehrenreich et al. (2020) studied this question.

synapsesocial.com/papers/6a85c94335bc0eada8d5b11ehttps://doi.org/10.1186/s10020-020-00186-y
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-192020 · 983 citations
  2. 2Compassionate Use of Remdesivir for Patients with Severe Covid-192020 · 2,909 citations
  3. 3Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial2002 · 1,028 citations
  4. 4A first case of meningitis/encephalitis associated with SARS-Coronavirus-22020 · 2,087 citations
  5. 5Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.1990 · 577 citations